From March 21 to March 23, a delegation from MLC, including representatives from the research and development department and laboratory staff, visited China's largest in vitro diagnostics exhibition, CACLP 2026 (Xiamen, China).
The 23rd China International In Vitro Diagnostic Expo (CACLP 2026) is an event recognized as the most influential platform in the IVD industry, attracting more than 1,300 exhibitors and 45,000 visitors from around the world: https://en.caclp.com/
The MLC delegation assessed the latest developments in the fields of artificial intelligence, primary diagnostics and internationalization.
The scale and level of solutions presented at the exhibition confirmed that the development of health technologies is a global trend that is steadily gaining momentum.
The CACLP 2026 exhibition was further proof for the MLC project that we are moving in the right direction.
Together, we are shaping a future where health diagnostics become more accurate, accessible, and seamless.
Support the development of MLC technologies. Join the project today, taking advantage of the current discount: starting April 1, the discount on investment shares in the first production line will be reduced by 20%.
